Is this the second stage of another drug scandal?
Wygovy, Oxempic and Mounjaro, as weight loss drugs, have been heavily promoted over the last 2+ years, despite conventional medicine knowing that they can cause serious adverse drug reactions. As usual, users of the drugs are not being informed about these ‘side effects’.
So back in February 2024 I asked the question - were we in the early stages of yet another medical scandal? And I reminded readers about the history of Acomplia, a weight loss drug that barely lasted two years before being banned.
Wygovy; Ozempic; Mounjaro: weight loss drugs, and the promotion of pharmaceutical drugs
The obesity/diabetes drugs, Wygovy, Ozempic, Mounjaro, have become a pharmaceutical best sellers. They are making the drug companies very wealthy! The active ingredient, semaglutide, helps control blood sugar, lowers appetite, and makes patients feel "full". The current claim of medical science is that all these semaglutide drugs can lead to weight loss…
Now in Britain, the Sun newspaper has reported that the drugs are now being linked with one death every week. It is thought that in the UK alone there are now over 1.5 million people taking these drugs, the numbers rising after the NHS made them available in June 2025.
Even so the paper tries to pull back when it says “It does not mean the injections, now being used by up to 1.5 million Britons, caused the deaths, only that they may have played a part”. Nor does it ask for an investigation into the possibility of drug-caused death to protect patients from drug harm. Indeed the article goes on to say that “On the basis of the current evidence, the benefits of GLP-1 medicines outweigh the potential risks when used for the licensed indications”. Who has made this statement? On what evidence has this judgement been made? We are not, of course, told!
The Independent Newspaper has also produced an article entitled, “Weight-loss jabs linked to hundreds of cases of life-threatening illness and 10 deaths”, adding that since the GLP-1 drugs, including Mounjaro, Ozempic and Wegovy, were licensed, there have been “hundreds of reported cases of acute and chronic pancreatitis among people taking them”. So it is not just death!
Several other news agencies have reported these deaths, which is unusual at this stage, such as the BBC, Sky News, Channel 4 News, even the British Medical Association, the Patient Safety Learning website, and even the Government website has seen fit to provide a “general reminder” about the known adverse reactions caused by the drugs. This is perhaps unusual - media outlets are generally quieter at this stage, in deference to their pharmaceutical paymasters!
However, this is the usual second-stage of an upcoming pharmaceutical scandal. The first stage is “the wonder drug” stage. The second stage concerns the denial, discounting, and justification of the harm caused to patients. Often, during this stage, conventional medicine seeks to find new uses and justifications for taking the drug, like this one recently reported on MIMS, “Semaglutide could correct prediabetes in people with schizophrenia on antibiotics”.
The third stage, for which we will now have to wait patiently, will come when the level and seriousness of patient harm becomes too difficult for government, conventional medicine, and the mainstream media to continue trying to justify.
So far, then, my prediction of another pharmaceutical medical scandal is on course!
